An innovative multi-step phase separation process was used to prepare tissue culture for the polystyrene-based, hierarchically structured substrates, which mimicked in vivo microenvironment and architecture. Macro- (pore area from 3000 to 18,000 µm2; roughness (Ra) 7.2 ± 0.1 µm) and meso- (pore area from 50 to 300 µm2; Ra 1.1 ± 0.1 µm) structured substrates covered with micro-pores (area around 3 µm2) were prepared and characterised. Both types of substrate were suitable for human-induced pluripotent stem cell (hiPSC) cultivation and were found to be beneficial for the induction of cardiomyogenesis in hiPSC. This was confirmed both by the number of promoted proliferated cells and the expressions of specific markers (Nkx2.5, MYH6, MYL2, and MYL7). Moreover, the substrates amplified the fluorescence signal when Ca2+ flow was monitored. This property, together with cytocompatibility, make this material especially suitable for in vitro studies of cell/material interactions within tissue-mimicking environments.

Centre of Polymer Systems Tomas Bata University in Zlin 760 01 Zlin Czech Republic

Faculty of Science Masaryk University 625 00 Brno Czech Republic

Faculty of Technology Tomas Bata University in Zlin 760 01 Zlin Czech Republic

Zobrazit více v PubMed

Pera M.F., Reubinoff B., Trounson A. Human embryonic stem cells. Pt 1J. Cell Sci. 2000;113:5–10. doi: 10.1242/jcs.113.1.5. PubMed DOI

Lo B., Parham L. Ethical issues in stem cell research. Endocr. Rev. 2009;30:204–213. doi: 10.1210/er.2008-0031. PubMed DOI PMC

Wilson H.K., Canfield S.G., Shusta E.V., Palecek S.P. Concise review: Tissue-specific microvascular endothelial cells derived from human pluripotent stem cells. Stem Cells. 2014;32:3037–3045. doi: 10.1002/stem.1797. PubMed DOI PMC

Wang F., Kong J., Cui Y.Y., Liu P., Wen J.Y. Is Human-induced Pluripotent Stem Cell the Best Optimal? Chin. Med. J. 2018;131:852–856. doi: 10.4103/0366-6999.228231. PubMed DOI PMC

Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676. doi: 10.1016/j.cell.2006.07.024. PubMed DOI

Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861–872. doi: 10.1016/j.cell.2007.11.019. PubMed DOI

Ye L., Swingen C., Zhang J. Induced pluripotent stem cells and their potential for basic and clinical sciences. Curr. Cardiol. Rev. 2013;9:63–72. doi: 10.2174/157340313805076278. PubMed DOI PMC

Zhang J., Wilson G.F., Soerens A.G., Koonce C.H., Yu J., Palecek S.P., Thomson J.A., Kamp T.J. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 2009;104:30–41. doi: 10.1161/CIRCRESAHA.108.192237. PubMed DOI PMC

Zwi L., Caspi O., Arbel G., Huber I., Gepstein A., Park I.H., Gepstein L. Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation. 2009;120:1513–1523. doi: 10.1161/CIRCULATIONAHA.109.868885. PubMed DOI

Csöbönyeiová M., Polák Š., Danišovič L. Perspectives of induced pluripotent stem cells for cardiovascular system regeneration. Exp. Biol. Med. 2015;240:549–556. doi: 10.1177/1535370214565976. PubMed DOI PMC

Nelson T.J., Martinez-Fernandez A., Yamada S., Perez-Terzic C., Ikeda Y., Terzic A. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation. 2009;120:408–416. doi: 10.1161/CIRCULATIONAHA.109.865154. PubMed DOI PMC

Carson D., Hnilova M., Yang X., Nemeth C.L., Tsui J.H., Smith A.S., Jiao A., Regnier M., Murry C.E., Tamerler C., et al. Nanotopography-Induced Structural Anisotropy and Sarcomere Development in Human Cardiomyocytes Derived from Induced Pluripotent Stem Cells. ACS Appl. Mater. Interfaces. 2016;8:21923–21932. doi: 10.1021/acsami.5b11671. PubMed DOI PMC

Xu C., Wang L., Yu Y., Yin F., Zhang X., Jiang L., Qin J. Bioinspired onion epithelium-like structure promotes the maturation of cardiomyocytes derived from human pluripotent stem cells. Biomater. Sci. 2017;5:1810–1819. doi: 10.1039/C7BM00132K. PubMed DOI

Muncie J.M., Weaver V.M. The Physical and Biochemical Properties of the Extracellular Matrix Regulate Cell Fate. Curr. Top. Dev. Biol. 2018;130:1–37. doi: 10.1016/bs.ctdb.2018.02.002. PubMed DOI PMC

Lien C.L., McAnally J., Richardson J.A., Olson E.N. Cardiac-specific activity of an Nkx2-5 enhancer requires an evolutionarily conserved Smad binding site. Dev. Biol. 2002;244:257–266. doi: 10.1006/dbio.2002.0603. PubMed DOI

Gelb B.D., Chin S.E. In: Chapter 34-Genetics of Congenital Heart Disease. Muscle Hill J.A., Olson E.N., editors. Academic Press; Boston/Waltham, MA, USA: 2012. pp. 473–480.

Cullup T., Lamont P.J., Cirak S., Damian M.S., Wallefeld W., Gooding R., Tan S.V., Sheehan J., Muntoni F., Abbs S., et al. Mutations in MYH7 cause Multi-minicore Disease (MmD) with variable cardiac involvement. Neuromuscul. Disord. 2012;22:1096–1104. doi: 10.1016/j.nmd.2012.06.007. PubMed DOI

McNally E., Dellefave L. Sarcomere mutations in cardiogenesis and ventricular noncompaction. Trends Cardiovasc. Med. 2009;19:17–21. doi: 10.1016/j.tcm.2009.03.003. PubMed DOI

England J., Loughna S. Heavy and light roles: Myosin in the morphogenesis of the heart. Cell Mol. Life Sci. 2013;70:1221–1239. doi: 10.1007/s00018-012-1131-1. PubMed DOI PMC

Elliott D.A., Braam S.R., Koutsis K., Ng E.S., Jenny R., Lagerqvist E.L., Biben C., Hatzistavrou T., Hirst C.E., Yu Q.C., et al. NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat. Methods. 2011;8:1037–1040. doi: 10.1038/nmeth.1740. PubMed DOI

Moses K.A., DeMayo F., Braun R.M., Reecy J.L., Schwartz R.J. Embryonic expression of an Nkx2-5/Cre gene using ROSA26 reporter mice. Genesis. 2001;31:176–180. doi: 10.1002/gene.10022. PubMed DOI

Louch W.E., Koivumäki J.T., Tavi P. Calcium signalling in developing cardiomyocytes: Implications for model systems and disease. J. Physiol. 2015;593:1047–1063. doi: 10.1113/jphysiol.2014.274712. PubMed DOI PMC

Minařík M., Wrzecionko E., Minařík A., Grulich O., Smolka P., Musilová L., Junkar I., Primc G., Ptošková B., Mozetič M., et al. Preparation of Hierarchically Structured Polystyrene Surfaces with Superhydrophobic Properties by Plasma-Assisted Fluorination. Coatings. 2019;9:201. doi: 10.3390/coatings9030201. DOI

Wrzecionko E., Minařík A., Smolka P., Minařík M., Humpolíček P., Rejmontová P., Mráček A., Minaříková M., Gřundělová L. Variations of Polymer Porous Surface Structures via the Time-Sequenced Dosing of Mixed Solvents. ACS Appl. Mater. Interfaces. 2017;9:6472–6481. doi: 10.1021/acsami.6b15774. PubMed DOI

Jasenská D., Kašpárková V., Radaszkiewicz K.A., Capáková Z., Pacherník J., Trchová M., Minařík A., Vajďák J., Bárta T., Stejskal J., et al. Conducting composite films based on chitosan or sodium hyaluronate. Properties and cytocompatibility with human induced pluripotent stem cells. Carbohydr. Polym. 2021;253:117244. doi: 10.1016/j.carbpol.2020.117244. PubMed DOI

Konopka R., Fau H.M., Kubala L., Fau K.L., Pacherník J. New luminescence-based approach to measurement of luciferase gene expression reporter activity and adenosine triphosphate-based determination of cell viability. Folia Biol. 2010;56:66–71. PubMed

Radaszkiewicz K.A., Sýkorová D., Karas P., Kudová J., Kohút L., Binó L., Večeřa J., Víteček J., Kubala L., Pacherník J. Simple non-invasive analysis of embryonic stem cell-derived cardiomyocytes beating in vitro. Rev. Sci. Instrum. 2016;87:024301. doi: 10.1063/1.4941776. PubMed DOI

Radaszkiewicz T., Nosková M., Gömöryová K., Vondálová Blanářová O., Radaszkiewicz K.A., Picková M., Víchová R., Gybel’ T., Kaiser K., Demková L., et al. RNF43 inhibits WNT5A driven signaling and suppresses melanoma invasion. bioRxiv. 2021 doi: 10.1101/2021.02.08.430210. PubMed DOI PMC

Controlled Structuring of Hyaluronan Films by Phase Separation and Inversion